Literature DB >> 22392580

Spontaneous recovery from anti-NMDAR encephalitis.

Amelia Evoli, Pietro Spinelli, Giovanni Frisullo, Paolo E Alboini, Serenella Servidei, Camillo Marra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22392580     DOI： 10.1007/s00415-012-6457-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Cognitive deficits following anti-NMDA receptor encephalitis.

Authors:  Carsten Finke; Ute A Kopp; Harald Prüss; Josep Dalmau; Klaus-Peter Wandinger; Christoph J Ploner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-20       Impact factor: 10.154

2.  Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis.

Authors:  H M H Braakman; V M P Moers-Hornikx; B M G Arts; R M M Hupperts; J Nicolai
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

Review 3.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

4.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

Review 5.  Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis.

Authors:  Klaus-Peter Wandinger; Sandra Saschenbrecker; Winfried Stoecker; Josep Dalmau
Journal:  J Neuroimmunol       Date:  2010-10-15       Impact factor: 3.478

6.  Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

Authors:  H Prüss; J Dalmau; L Harms; M Höltje; G Ahnert-Hilger; K Borowski; W Stoecker; K P Wandinger
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

7.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

8.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910
  8 in total
  8 in total

1.  Autoimmune limbic encephalitis presenting as relapsing psychosis.

Authors:  Sarah A Hopkins; Kuven K Moodley; Dennis Chan
Journal:  BMJ Case Rep       Date:  2013-08-30

2.  The witchcraft of encephalitis in Salem.

Authors:  Johnny Tam; Michael S Zandi
Journal:  J Neurol       Date:  2017-06-19       Impact factor: 4.849

3.  The Expression and Significance of the Plasma Let-7 Family in Anti-N-methyl-D-aspartate Receptor Encephalitis.

Authors:  Jing Zhang; Xiaoge Xu; Shaoyun Zhao; Zhe Gong; Peidong Liu; Wenjuan Guan; Xia He; Tianshu Wang; Tao Peng; Junfang Teng; Yanjie Jia
Journal:  J Mol Neurosci       Date:  2015-01-22       Impact factor: 3.444

4.  Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders.

Authors:  Pei-Chen Hsieh; Yih-Ru Wu
Journal:  J Mov Disord       Date:  2022-05-26

5.  Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Authors:  Adam Al-Diwani; Thomas A Pollak; Alexander E Langford; Belinda R Lennox
Journal:  Front Psychiatry       Date:  2017-02-06       Impact factor: 4.157

6.  Olanzapine and Lorazepam Used in the Symptomatic Management of Excited Catatonia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Authors:  Namita Neerukonda; Michael Bliss; Abtin Jafroodifar; Luba Leontieva
Journal:  Cureus       Date:  2020-06-18

7.  Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis.

Authors:  Dominica Ratuszny; Thomas Skripuletz; Florian Wegner; Matthias Groß; Christine Falk; Roland Jacobs; Heiner Ruschulte; Martin Stangel; Kurt-Wolfram Sühs
Journal:  Front Neurol       Date:  2020-12-22       Impact factor: 4.003

Review 8.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Detailed Review of the Different Psychiatric Presentations and Red Flags to Look for in Suspected Cases.

Authors:  Ghasaq K Subeh; Mehreen Lajber; Talha Patel; Jihan A Mostafa
Journal:  Cureus       Date:  2021-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.